Brian Conrad

Brian Conrad has a diverse work experience spanning various industries. Brian is currently working as a Business Development Specialist for US Biopharma at Cerba Research. In this role, they provide scientific and operational support for clinical trials and oversees specialized testing services.

Before joining Cerba Research, Brian worked at Enzo Life Sciences, Inc. for several years. Brian held roles as a Sales Support Specialist where they answered customer inquiries, provided technical support, and maintained the CRM database.

Brian also gained healthcare experience working at Lourdes Hospital as a Patient Care Assistant. Brian assisted licensed medical staff with procedures, conducted assessments, and maintained supplies and equipment.

In their earlier career, Brian worked at Binghamton University in different capacities. As a Graduate Teaching Assistant, they instructed and supported students in the field of Cell and Molecular Biology. Brian also interned with the Department of Sports Medicine, observing and assisting team physicians.

Brian's experience also includes an internship at UHS Hospitals, where they worked in the Operating Room, Orthopedics, and Post Anesthesia Care Unit. Brian assisted surgical personnel in preparing and sterilizing operating rooms.

Lastly, Brian served as an Event Manager for ResLife Binghamton at Binghamton University. Brian assisted with venue setup and breakdown and was responsible for managing facilities.

Overall, Brian Conrad has a strong background in business development, customer support, healthcare, teaching, and event management.

Brian Conrad completed their Bachelor of Science (B.S.) in Integrative Neuroscience (Molecular) from Binghamton University, starting in 2011 and finishing in 2015. Following that, they pursued a Master's degree, attaining a Master of Arts (M.A.) in Biology/Biological Sciences, General from Binghamton University, which they completed from 2015 to 2016. In terms of additional certifications, Brian obtained a Certificate of Achievement in HMX Pro Immunology - Immuno-Oncology from Harvard Medical School in November 2021. Brian also completed the Good Clinical Practice (GCP), Version 5 certification from The National Institute on Drug Abuse (NIDA) in June 2023. Furthermore, they acquired the BLS for Healthcare Providers certification from the American Heart Association | American Stroke Association in January 2016.